基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Background: Gemcitabine is a deoxycytidine analog, which is used as first-line agent for pancreatic cancer therapy, and its efficacy relied on its intracellular conversion to active triphosphate form. However, administration with gemcitabine still has limited effect on the overall survival of patients with pancreatic cancer. Objective: We aimed to study the combination effect of gemcitabine and doxorubicin to pancreatic cancer cells BxPC3 and PANC1, and unveil the mechanism. Methods: The study was performed in pancreatic cancer cells PANC1 and BxPC3, the contribution of UMP/CMP kinase 1 (CMPK1) to gemcitabine in PANC1 and BxPC3 cells was measured by transfection of CMPK1 plasmid or CMPK1 siRNA treatment to adjust the expression of CMPK1 in the cells;then analyzed the cell vitality and migration after treated with 1% IC50 of doxorubicin and gemcitabine or only with gemcitabine;the activity of CMPK1 and the effect of doxorubicin to the reaction was measured by HPLC assay in vitro;at last, docking analysis by computer was used to calculate the possible interaction sites of CMPK1 to DOX. Results: The sensitivity of PANC1 and BxPC3 cells to gemcitabine was improved when increasing the expression of CMPK1, and decreased when knockout CMPK1 by CMPK1 siRNA in BxPC3 cells;when combined with doxorubicin, the sensitivity of PANC1 and BxPC3 cells to gemcitabine also increased, and the cells migration reduced;we further found out that by adding 10 μM doxorubicin, the catalyzing activity of CMPK1 elevated about 2 times in vitro;the docking result showed that the association of CMPK1 to DOX was mainly by hydrogen bond and ionic interaction. Conclusion: CMPK1 can catalyze gemcitabine to its active form within the cells so that the sensitivity of the cells to gemcitabine elevated, and doxorubicin may enhance the cytotoxic effect to pancreatic cancer by up-regulate the activity of CMPK1, the combination of these deoxycytidine analogs with DOX might exert better efficacy.
推荐文章
牛磺酸对胰腺癌细胞系BxPC-3和PANC-1细胞增殖、 凋亡和迁移的影响
牛磺酸
胰腺肿瘤
肿瘤抑制蛋白质p53
周期素依赖激酶抑制剂p21
细胞周期蛋白类
周期蛋白依赖性激酶
Rab5在胰腺癌细胞BxPC3中对Notch1活性的调节
胰腺癌
BxPC3
Notch1
Rah5
Wortmannin
LY294002
内吞
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1
来源期刊 生物科学与医学(英文) 学科 医学
关键词 GEMCITABINE DEOXYCYTIDINE ANALOG DOXORUBICIN CMPK1 Pancreatic Cancer
年,卷(期) 2017,(10) 所属期刊栏目
研究方向 页码范围 64-74
页数 11页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2017(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
GEMCITABINE
DEOXYCYTIDINE
ANALOG
DOXORUBICIN
CMPK1
Pancreatic
Cancer
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
生物科学与医学(英文)
月刊
2327-5081
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
721
总下载数(次)
0
总被引数(次)
0
论文1v1指导